Glioblastoma — Trials

Glioblastoma — Trials · CancerIndex

Clinical trials

Registered studies

1,750 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 486
Recruiting: 258
Ph III recruiting: 13
Growth YoY: +41%
Industry share: 19%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (282)

clinicaltrialsPublishedShowing 101–103 of 103 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00548938	Gliadel Wafer, Temozolomide and Radiation Therapy for Newly Diagnosed GBM	terminated	Phase 2	40	Methodist Healthcare - MemphisOTHER	1	Sep 18, 2009	clinicaltrials
NCT00365222	Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma	terminated	Phase 2	1	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Jan 22, 2009	clinicaltrials